Daan Biotherapeutics

Daan Biotherapeutics

Private
SeoulHealthcare & Life Scienceshttps://daanbiotpx.com/

Last Round

Series A

Jan 25, 2024

Est. Valuation

$20.5M

Total Funding Raised

$21.3M

Company Overview

Daan Biotherapeutics is a biotechnology company that develops treatments for cancer including cell therapies, antibodies, and small molecule inhibitors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

TCR-T cell therapysolid tumor treatmentantibody-drug conjugateADCcell therapyimmunotherapyimmuno-oncologyPRAME antigenT-cell engageroncology therapeuticssmall molecule inhibitorantibody discoveryclinical-stage biotechAttenTCR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Daan Biotherapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Daan Biotherapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AJan 25, 2024
SeedMar 28, 2022

Daan Biotherapeutics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 25, 2024

    $17M round led by Paratus Investment and Timefolio Asset Management.

  • Mar 28, 2022

    $4M round with participation from Timefolio Asset Management and Company K Partners.

Daan Biotherapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Daan Biotherapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Daan Biotherapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Year Founded2020
Last FundingJan 25, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.